The Goserelin Acetate Sustained Release Implant market continues to expand as oncologists and endocrinologists increasingly rely on this luteinizing hormone-releasing hormone (LHRH) agonist for managing hormone-sensitive conditions. Goserelin acetate works by initially stimulating and then suppressing pituitary gonadotropin secretion, leading to reduced production of sex hormones such as...